Srilatha Edupuganti

Also affiliated with University of Zimbabwe, University of California, San Francisco

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans”.

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Science(2020)10.1126/science.abc6261

N/A

12.3DataRank · unranked

1345 citations

Florian Wimmers, Chris Ka Pun Mok, Ranawaka A. P. M. Perera, Madeleine Scott, Thomas Hagan +26 more

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine(2022)10.1056/nejmoa2116414

N/A

9.7DataRank · unranked

618 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100679

N/A

5.1DataRank · unranked

167 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul Paul Chourdhury +64 more

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

medRxiv(2021)10.1101/2021.10.10.21264827

N/A

5.1DataRank · unranked

98 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

The Lancet HIV(2020)10.1016/s2352-3018(20)30229-0

N/A

2.7DataRank · unranked

91 citations

Daniel J Stieh, Michal Sarnecki, Stephen R. Walsh, Georgia D. Tomaras, James G. Kublin +36 more

Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab111

N/A

2.3DataRank · unranked

21 citations

Jack T. Stapleton, Zuhair K. Ballas, Wendy Rasmussen, Thomas M. Kaufman, Tammy P Blevins +24 more

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00052-4

N/A

1.1DataRank · unranked

39 citations

Srilatha Edupuganti, Grace Chen, Myra Happe, Larisa Strom, Alicia T. Widge +67 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

JCI Insight(2020)10.1172/jci.insight.137079

N/A

1.0DataRank · unranked

49 citations

Srilatha Edupuganti, Yunda Huang, Xue Han, Marnie Elizaga, Edith Swann +23 more

EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

Trials(2022)10.1186/s13063-022-05997-4

N/A

0.941DataRank · unranked

31 citations

Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy +13 more

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100354

N/A

0.920DataRank · unranked

459 citations

Susanne L. Linderman, Zoe Moodie, Julie Czartoski, Lilin Lai, Grace Mantus +28 more

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac445

N/A

0.872DataRank · unranked

36 citations

Dan H. Barouch, Christy Comeaux, Michal Sarnecki, Kathryn E. Stephenson, Stephen R. Walsh +43 more

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

Journal of Clinical Investigation(2023)10.1172/jci163338

N/A

0.553DataRank · unranked

14 citations

Andrew Fioré-Gartland, Stephen R. Walsh, Karina Yusim, Nicole Frahm, Marnie Elizaga +25 more

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad434

N/A

0.395DataRank · unranked

7 citations

Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C. deCamp, Zonglin He +27 more

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad441

N/A

0.390DataRank · unranked

9 citations

Rachel L. Edwards, Mei Xia, Christopher S. Eickhoff, Fahreta Hamzabegovic, Krystal A. Meza +20 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf176

N/A

0.284DataRank · unranked

4 citations

Kirsten E. Lyke, Christine M. Posavad, Meagan E. Deming, Rebecca C. Brady, David Dobrzynski +32 more

Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes

EBioMedicine(2023)10.1016/j.ebiom.2023.104875

N/A

0.104DataRank · unranked

1 citations

Daniel Espinoza, Yerun Zhu, Jaime A. Cardona‐Ospina, Natalie M. Bowman, Sylvia Becker‐Dreps +9 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

UNC Libraries(2023)10.17615/q13b-q658

N/A

0DataRank · unranked

0 citations

Srilatha Edupuganti, Shelly Karuna, Michal Juraska, Nonhlanhla N. Mkhize, P. Andrew +16 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies

The Journal of Experimental Medicine(2024)10.1084/jem.20240604

N/A

0DataRank · unranked

29 citations

K. Rachael Parks, Mingchao Shen, Gabriel Ozorowski, Holly Janes, Lamar M. Fleming +32 more

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

npj Vaccines(2024)10.1038/s41541-024-00833-z

N/A

0DataRank · unranked

19 citations

Amelia R. Hofstetter, Jing Wang, Galina V. Yamshchikov, LaSonji A. Holman, Laura Novik +93 more

Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2322982122

N/A

0DataRank · unranked

7 citations

Rama Akondy, Shu Yang, Srilatha Edupuganti, Shashi Nagar, Garett Michael +7 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

UNC Libraries(2025)10.17615/8kk4-f682

N/A

0DataRank · unranked

0 citations

Jared M. Baeten, Deborah Donnell, Glenda Gray, Linda‐Gail Bekker, Srilatha Edupuganti +9 more

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100040

N/A

0DataRank · unranked

547 citations

Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, William Henry Hudson +33 more

COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva

Journal of Clinical Microbiology(2020)10.1128/jcm.02204-20

N/A

0DataRank · unranked

260 citations

Pranay R. Randad, Kate Kruczynski, Yukari C. Manabe, David L. Thomas, Andrew Pekosz +16 more

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Vaccines(2020)10.3390/vaccines8040741

N/A

0DataRank · unranked

27 citations

Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang +21 more

Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure

Vaccines(2020)10.3390/vaccines8030348

N/A

0DataRank · unranked

5 citations

Kevin A. Ault, Nadine Rouphael, Allison Beck, Briyana Domjahn, Yongxian Xu +13 more

Rapid generation of neutralizing antibody responses in COVID-19 patients

medRxiv(2020)10.1101/2020.05.03.20084442

N/A

0DataRank · unranked

108 citations

Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, Abigail Vanderheiden +32 more

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science(2021)10.1126/science.abj4176

N/A

0DataRank · unranked

602 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +82 more

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

Cell Host & Microbe(2021)10.1016/j.chom.2021.03.009

N/A

0DataRank · unranked

250 citations

Carson Norwood, Katharine Floyd, Lilin Lai, Meredith E. Davis-Gardner, William Henry Hudson +29 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study

Infection Control and Hospital Epidemiology(2021)10.1017/ice.2021.54

N/A

0DataRank · unranked

16 citations

Carly Adams, Amy C Sherman, William Dube, Teresa Smith, Neena Edupuganti +12 more

Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain

The Journal of Immunology(2021)10.4049/jimmunol.2001420

N/A

0DataRank · unranked

14 citations

Lindsay E. Nyhoff, Robert C. Kauffman, Venkata Viswanadh Edara, Lilin Lai, Katharine Floyd +12 more

Application of SARS-CoV-2 Serology to Address Public Health Priorities

Frontiers in Public Health(2021)10.3389/fpubh.2021.744535

N/A

0DataRank · unranked

4 citations

Teresa Smith, Yerun Zhu, Kaitlin R. Taibl, Jessica Howard‐Anderson, Taylor Landay +20 more

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

medRxiv(2021)10.1101/2021.04.19.21255739

N/A

0DataRank · unranked

98 citations

Susanne L. Linderman, Zoe Moodie, Julie Czartoski, Lilin Lai, Grace Mantus +28 more

Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.20.432046

N/A

0DataRank · unranked

42 citations

Carson Norwood, Katharine Floyd, Lilin Lai, Meredith E. Davis-Gardner, William Henry Hudson +29 more

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Journal of Clinical Oncology(2022)10.1200/jco.21.02986

N/A

0DataRank · unranked

43 citations

Jennifer W. Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai +34 more

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study

Infection Control and Hospital Epidemiology(2022)10.1017/ice.2021.518

N/A

0DataRank · unranked

11 citations

Carly Adams, William Dube, Teresa Smith, Amy C Sherman, Neena Edupuganti +13 more

Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern

medRxiv(2022)10.1101/2022.01.03.22268599

N/A

0DataRank · unranked

13 citations

Jennifer W. Carlisle, Susanne L. Linderman, Akil Akthar, Ralph Linwood Millett, Lilin Lai +34 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

Journal of the International AIDS Society(2023)10.1002/jia2.26118

N/A

0DataRank · unranked

11 citations

Fei Gao, James P. Hughes, Brett Hanscom, Lawrence Corey, Myron S. Cohen +9 more